Mount Sinai Receives $100,000 from The Honest Company for Inaugural Children’s Environmental Health Innovation Grant
Will support research about how environment influences health throughout life
The Honest Company has awarded The Institute for Exposomics Research at Mount Sinai $100,000 to fund two postdoctoral fellows conducting research in children’s environmental health. Click here to watch a video about the grant.
The grant recipients are Erik de Water, PhD, and Jeanette Stingone, PhD. Each fellow will receive $50,000 to fund their research programs. Dr. de Water will study the effects of maternal metal exposure on their children's developing brains. Dr. Stingone will study the correlation between prenatal and early life exposures to environmental chemicals and early puberty, a risk factor for adult adverse health outcomes including breast cancer and cardiovascular disease.
In 2014, Mount Sinai Health System partnered with The Honest Company to open The Honest Company Ultra Clean Room. Part of the Senator Frank R. Lautenberg Environmental Health Sciences Laboratory, the state-of-the-art facility measures the impact of chemicals in the environment on children’s health. The Honest Company Ultra Clean Room is the “gold standard” in analytical chemistry laboratories. It is equipped with technologies that significantly reduce the risk of sample contamination and allow researchers to measure extremely low levels of exposures—even levels as small as parts per trillion.
“There has been a big push to understand the genetic contributions of disease, but not as big an effort to uncover the environmental ones,” said Robert Wright, MD, Chair, Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai. “By providing this funding, The Honest Company has partnered with Mount Sinai in a way that allows us the freedom to determine what environmental factors are most important for children’s health and development. We are grateful to The Honest Company for powering these opportunities for environmental health and science and nurturing our most promising young scientists to devote their talent and efforts to our field.”
“Mount Sinai has been an important partner to us since 2014, and we are proud to further this longstanding relationship by supporting these meaningful research efforts through the Children’s Environmental Health Innovation Grant,” said Christopher Gavigan, Co-Founder and Chief Purpose Officer of The Honest Company. “The Honest Company is committed to helping drive the change we want to see in the world and believes that research initiatives such as these will ultimately help us create a safer, healthier world for children and families.”
About The Honest Company
The Honest Company is dedicated to helping people live happy and healthy lives. Founded in 2012, the mission-driven company provides 100+ safe and effective products across a wide range of consumer categories, including baby, personal care, beauty, home care, and vitamins & supplements, to a passionate community of consumers united by values and style. Honest products are available across the U.S. via honest.com and honestbeauty.com and at more than 17,000 retail locations across North America. The Honest Company is privately held and headquartered in Los Angeles, California.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology, Mount Sinai St. Lukes and Mount Sinai West are ranked 23rd nationally for Nephrology and 25th for Diabetes/Endocrinology, and Mount Sinai South Nassau is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and Mount Sinai South Nassau are ranked regionally.